Former FDA lawyer Laurie Clarke joins TSG Consulting to lead medical device practice
WASHINGTON DC – 10 March, 2021: Laurie Clarke, JD, MPP joins TSG Consulting as Vice President & Principal of the company’s medical device regulatory practice. With over 25...
Former FDA lawyer Laurie Clarke joins TSG Consulting to lead medical device practice
WASHINGTON DC – 10 March, 2021: Laurie Clarke, JD, MPP joins TSG Consulting as Vice President & Principal of the company’s medical device regulatory practice. With over 25...
TSG strengthens ecotoxicology expertise with the appointment of Jennifer Duncan
TSG welcomes Jennifer Duncan, former Regulator at the UK Pesticide Safety Directorate (now CRD). With 20 years’...
Renewal of authorisation for plant protection products: three ways to help it run smoothly
EU authorisation of an active substance (AS) for PPP applications generally expires after ten years. Well in advance of...
Putting FDA regulatory strategy at the heart of medical device development
Laurie Clarke recently joined TSG Consulting to head up our medical device regulatory practice. Having formerly worked...
Ailsa Jackson appointed President of the American Board of Toxicology
Congratulations to TSG Consulting’s Ailsa Jackson, BSc, DABT, who has been appointed President of the American Board...
Biopesticides, Plant Growth Regulators, and Biostimulants: 5 questions about the US regulatory framework answered
TSG Consulting recently hosted a panel discussion exploring the process of registering new products in these...
Professionals
Our regulatory specialists and scientists address all aspects of product registration and ongoing compliance. Read more about the individuals who make up our multi-disciplinary teams.
